|
Volumn 21, Issue 15, 2002, Pages 2243-2255
|
On the issue of 'multiple' first failures in competing risks analysis
|
Author keywords
'Tied' first failure; Competing risks
|
Indexed keywords
BLEOMYCIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DACTINOMYCIN;
DOXORUBICIN;
METHOTREXATE;
ANALYTICAL ERROR;
ARTICLE;
CANCER RECURRENCE;
CANCER RESEARCH;
COMPUTER PROGRAM;
CONTROLLED STUDY;
FOLLOW UP;
HUMAN;
INTERMETHOD COMPARISON;
METHODOLOGY;
OSTEOSARCOMA;
RECURRENCE RISK;
RISK ASSESSMENT;
STATISTICAL ANALYSIS;
TREATMENT FAILURE;
ANTINEOPLASTIC AGENTS;
BONE NEOPLASMS;
DISEASE-FREE SURVIVAL;
HUMANS;
NEOPLASM RECURRENCE, LOCAL;
OSTEOSARCOMA;
PROPORTIONAL HAZARDS MODELS;
RANDOMIZED CONTROLLED TRIALS;
STATISTICS;
TREATMENT FAILURE;
|
EID: 0037102911
PISSN: 02776715
EISSN: None
Source Type: Journal
DOI: 10.1002/sim.1208 Document Type: Article |
Times cited : (18)
|
References (24)
|